Literature DB >> 18925908

Donor infection and transmission to the recipient of a solid allograft.

O Len1, J Gavaldà, M Blanes, M Montejo, R San Juan, A Moreno, J Carratalà, J de la Torre-Cisneros, G Bou, E Cordero, P Muñoz, V Cuervas-Mons, M T Alvarez, N Borrell, J Fortun, A Pahissa.   

Abstract

Transmission of infection from donor to recipient is a potential complication of transplantation. More data on this issue are needed to expand the insufficient donor pool. This study evaluates the incidence of donor nonviral infection, transmission from infected donors and the effect of donor infection on 30-day recipient survival. Data from 211 infected donors contributing to 292 (8.8%) of 3322 consecutive transplant procedures within RESITRA (Spanish Research Network for the Study of Infection in Transplantation) were prospectively compiled and analyzed. Lung was the most likely transplanted organ carried out with an infected donor and Staphylococcus aureus was the most commonly isolated microorganism. In more than a half of donors, the lung was the site of infection. Donor-to-host transmission was documented in 5 patients out of 292 (1.71%), 2 of whom died of the acquired infection (40%). Nonetheless, there was no difference in 30-day patient survival when comparing transplant procedures performed with organs from infected or uninfected donors. In conclusion, donor infection is not an infrequent event, but transmission to the recipient is quite low. Hence, with careful microbiological surveillance and treatment, the number of organs available for transplantation may be increased.

Entities:  

Mesh:

Year:  2008        PMID: 18925908     DOI: 10.1111/j.1600-6143.2008.02397.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  16 in total

Review 1.  Bloodstream infections after solid-organ transplantation.

Authors:  Antonios Kritikos; Oriol Manuel
Journal:  Virulence       Date:  2016-01-14       Impact factor: 5.882

Review 2.  Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcome.

Authors:  A M James Shapiro
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 3.  Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.

Authors:  Christopher S Kovacs; Christine E Koval; David van Duin; Amanda Guedes de Morais; Blanca E Gonzalez; Robin K Avery; Steven D Mawhorter; Kyle D Brizendine; Eric D Cober; Cyndee Miranda; Rabin K Shrestha; Lucileia Teixeira; Sherif B Mossad
Journal:  World J Transplant       Date:  2014-06-24

Review 4.  Opportunistic infections--coming to the limits of immunosuppression?

Authors:  Jay A Fishman
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

5.  Three Cases of Neurologic Syndrome Caused by Donor-Derived Microsporidiosis.

Authors:  Rachel M Smith; Atis Muehlenbachs; Joanna Schaenmann; Sanjiv Baxi; Sophia Koo; Dianna Blau; Peter Chin-Hong; Anna R Thorner; Matthew J Kuehnert; Kristina Wheeler; Alexis Liakos; Jonathan W Jackson; Theresa Benedict; Alexandre J da Silva; Jana M Ritter; Dominique Rollin; Maureen Metcalfe; Cynthia S Goldsmith; Govinda S Visvesvara; Sridhar V Basavaraju; Sherif Zaki
Journal:  Emerg Infect Dis       Date:  2017-03       Impact factor: 6.883

6.  Controversies and emerging topics in lung transplantation.

Authors:  David Abelson; Allan R Glanville
Journal:  Breathe (Sheff)       Date:  2018-12

Review 7.  Infection in the process of organ donation.

Authors:  O Len Abad
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

Review 8.  Transplant infectious disease: implications for critical care nurses.

Authors:  Sandra A Cupples
Journal:  Crit Care Nurs Clin North Am       Date:  2011-09       Impact factor: 1.326

9.  The Etiology, Incidence, and Impact of Preservation Fluid Contamination during Liver Transplantation.

Authors:  Isabel Oriol; Laura Lladó; Marina Vila; Carme Baliellas; Fe Tubau; Núria Sabé; Joan Fabregat; Jordi Carratalà
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

10.  Update in Infectious Diseases 2019.

Authors:  F J Candel; C M Rico; I Díaz de la Torre; B Laguna; J Martínez-Jordán; S Medrano; M C Escobar-Porcel; A López-Delgado; L López-González; J M Viñuela-Prieto; M Matesanz; J González Del Castillo; A Arribi
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.